The AIM market has been overlooked, under loved, and undervalued for years. But today, after a long winter, the signs of a major turning point are flashing everywhere — and in some ways, the current global uncertainty, including the Iran conflict, is actually accelerating the opportunity rather than diminishing it. Markets dislike uncertainty, and we have plenty of it right now.
But history is clear:
“Buy to the sound of cannons, sell to the sound of trumpets.”
This has never been more relevant.
Global tensions — including rising oil prices, volatile equity markets, and emergency G7 discussions — have created a backdrop of fear and rapid market swings.
Yet these moments often precede the strongest long‑term opportunities, particularly in areas already priced for pessimism, like AIM.
The Critical Point for Investors: AIM Thrives in Dislocations
When the large‑cap indices wobble, when global macro is chaotic, when headlines scream fear — AIM has historically offered asymmetric upside for long‑term investors.
Here’s why AIM may actually be better positioned today than at any time in over a decade — even with war in the Middle East.
- AIM valuations are at generational lows
UK small caps are trading at a 25% discount to large caps — an extreme valuation gap near historic lows. This is not speculation; it’s statistically rare, and such dislocations often precede multi‑year rebounds.
High‑quality AIM companies are trading at:
- 12–14x PE
- Often half the valuation of similar US peers
- In many cases, sitting on huge net cash balances
Even with geopolitical risk rising, AIM’s valuations already price in a lot of bad news — arguably far too much.
- Cash-Rich AIM Leaders Are Weather‑Proof
Many AIM constituents hold 30–50% of their market cap in net cash. They aren’t exposed to expensive debt markets. They aren’t reliant on fragile credit conditions.
In a world of rising oil, rising inflation, rising uncertainty…
cash is king, and AIM companies have plenty.
- Dividends and Income Strengthen the Case
For the first time in 20 years, UK small-cap yields exceed those of the FTSE 100.
And AIM dividend payers regularly deliver 5–10%+ yields, well above inflation.
In turbulent markets, being paid to wait matters.
- AIM’s Technology, Healthcare & Specialist Firms Are Still Growing
Even during the broad sell‑offs, companies with:
- Proprietary data
- High switching costs
- Defensive recurring revenues
- AI‑aligned strategies
…have held up far better.
The Iran war may be rattling global markets, but it hasn’t changed the fundamentals of high‑quality AIM businesses.
- When Fear Spikes, Opportunities Expand
The Iran conflict has created:
- A global oil shock
- Investor panic
- Market volatility
- A sell‑first‑ask‑questions‑later mentality
Yet historically, markets overreact to geopolitical events before mean‑reverting.
AIM, already depressed for years, is not the source of the crisis — but it may become one of the biggest beneficiaries on the rebound.
Investors who wait for “certainty” rarely catch the best opportunities.
Investors who act during dislocation often do. Those already in AIM, need not do anything. You are ready to take advantage of the opportunity.
This is a rare moment – so what should investors do NOW?
AIM is cheap.
Quality is high.
Growth potential is huge.
Dividends appealing.
And ISA season is here.
Clients can:
- Transfer existing ISAs to us — moving from low‑growth large caps into high‑potential AIM portfolios
- Invest this year’s £20,000 ISA allowance
- Position early for a potential multi‑year rerating in small caps
- Maintain IHT benefits with qualifying AIM shares (even as rules change, AIM still offers 50% Business Relief after April)
You’re buying at the point of maximum pessimism — and historically, that’s where the biggest returns have come from.
If you have any questions or would like to speak about the portfolio performance, please contact us on 01923 713890 or email [email protected].
